$MLAB
MESA LABORATORIES INC /CO/

2020 Q1 Form 10-Q Financial Statement

#000143774920002116 Filed on February 10, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q4 2019 Q1
Revenue $34.21M $31.66M $26.45M
YoY Change 29.35% 18.64% -1.62%
Cost Of Revenue $15.57M $16.85M $10.83M
YoY Change 43.77% 52.53% -0.18%
Gross Profit $18.77M $14.80M $15.61M
YoY Change 20.21% -5.32% -2.62%
Gross Profit Margin 54.87% 46.76% 59.04%
Selling, General & Admin $15.38M $15.67M $10.98M
YoY Change 40.07% 60.16% 27.08%
% of Gross Profit 81.94% 105.87% 70.32%
Research & Development $2.310M $2.110M $970.0K
YoY Change 138.14% 145.35% 29.33%
% of Gross Profit 12.31% 14.25% 6.21%
Depreciation & Amortization $5.490M $3.060M $2.270M
YoY Change 141.85% 34.8% -8.84%
% of Gross Profit 29.25% 20.67% 14.54%
Operating Expenses $17.69M $18.06M $11.95M
YoY Change 48.03% 26.16% 27.26%
Operating Profit $1.079M -$3.255M $3.664M
YoY Change -70.55% -346.59% -44.85%
Interest Expense -$1.020M $1.929M
YoY Change 388.35%
% of Operating Profit -94.53%
Other Income/Expense, Net -$270.0K -$1.822M -$590.0K
YoY Change -54.24% -8021.74% 168.18%
Pretax Income -$390.0K -$5.077M $1.970M
YoY Change -119.8% -635.55% -69.31%
Income Tax $1.290M -$573.0K $570.0K
% Of Pretax Income 28.93%
Net Earnings -$1.680M -$4.500M $1.400M
YoY Change -220.0% -623.26% -67.06%
Net Earnings / Revenue -4.91% -14.22% 5.29%
Basic Earnings Per Share -$0.37 -$1.03 $0.36
Diluted Earnings Per Share -$0.37 -$1.03 $0.34
COMMON SHARES
Basic Shares Outstanding 4.370M 4.367M
Diluted Shares Outstanding 4.367M

Balance Sheet

Concept 2020 Q1 2019 Q4 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $81.40M $74.00M $10.20M
YoY Change 698.04% 1198.25% 85.45%
Cash & Equivalents $81.38M $73.98M $10.19M
Short-Term Investments
Other Short-Term Assets $6.100M $8.400M $4.200M
YoY Change 45.24% 40.0% 40.0%
Inventory $11.18M $18.80M $6.772M
Prepaid Expenses
Receivables $21.13M $19.50M $12.52M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $122.8M $120.7M $33.62M
YoY Change 265.2% 270.7% 5.11%
LONG-TERM ASSETS
Property, Plant & Equipment $22.07M $22.35M $22.23M
YoY Change -0.72% -2.8% -5.8%
Goodwill $141.5M $189.6M $66.38M
YoY Change 113.23% 195.56% 1.27%
Intangibles $119.9M $88.08M $33.22M
YoY Change 260.85% 129.75% -22.48%
Long-Term Investments
YoY Change
Other Assets $2.480M $2.513M
YoY Change 2413.0%
Total Long-Term Assets $286.3M $302.8M $123.1M
YoY Change 132.51% 141.06% -6.79%
TOTAL ASSETS
Total Short-Term Assets $122.8M $120.7M $33.62M
Total Long-Term Assets $286.3M $302.8M $123.1M
Total Assets $409.1M $423.5M $156.8M
YoY Change 160.97% 167.75% -4.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.408M $3.780M $2.898M
YoY Change 17.6% 55.81% 21.76%
Accrued Expenses $6.605M $8.005M $4.004M
YoY Change 64.96% 149.61% 19.06%
Deferred Revenue $6.814M $6.363M $3.965M
YoY Change 71.85% 70.68% 1.12%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.125M
YoY Change 30.77%
Total Short-Term Liabilities $26.01M $25.25M $23.66M
YoY Change 9.92% 21.47% 36.85%
LONG-TERM LIABILITIES
Long-Term Debt $140.3M $139.0M $20.61M
YoY Change 580.64% 410.79% -53.82%
Other Long-Term Liabilities $1.358M $1.382M $105.0K
YoY Change 1193.33% 1112.28% -45.88%
Total Long-Term Liabilities $1.358M $1.382M $20.72M
YoY Change -93.45% -94.94% -53.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.01M $25.25M $23.66M
Total Long-Term Liabilities $1.358M $1.382M $20.72M
Total Liabilities $189.1M $189.3M $45.46M
YoY Change 316.0% 274.35% -29.79%
SHAREHOLDERS EQUITY
Retained Earnings $72.36M $74.31M $73.30M
YoY Change -1.29% 2.47% 7.35%
Common Stock $158.0M $155.6M $39.82M
YoY Change 296.81% 326.03% 30.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $220.0M $235.3M $111.3M
YoY Change
Total Liabilities & Shareholders Equity $409.1M $423.5M $156.8M
YoY Change 160.97% 167.75% -4.47%

Cashflow Statement

Concept 2020 Q1 2019 Q4 2019 Q1
OPERATING ACTIVITIES
Net Income -$1.680M -$4.500M $1.400M
YoY Change -220.0% -623.26% -67.06%
Depreciation, Depletion And Amortization $5.490M $3.060M $2.270M
YoY Change 141.85% 34.8% -8.84%
Cash From Operating Activities $8.830M $11.01M $10.26M
YoY Change -13.94% 9.12% 6.43%
INVESTING ACTIVITIES
Capital Expenditures -$560.0K -$400.0K -$50.00K
YoY Change 1020.0% 11.11% -80.77%
Acquisitions
YoY Change
Other Investing Activities $10.00K -$181.5M $0.00
YoY Change 3650.83% -100.0%
Cash From Investing Activities -$550.0K -$181.9M -$50.00K
YoY Change 1000.0% 3398.85% -85.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 400.0K -360.0K -5.610M
YoY Change -107.13% -92.44% -43.33%
NET CHANGE
Cash From Operating Activities 8.830M 11.01M 10.26M
Cash From Investing Activities -550.0K -181.9M -50.00K
Cash From Financing Activities 400.0K -360.0K -5.610M
Net Change In Cash 8.680M -171.3M 4.600M
YoY Change 88.7% -131861.54% -866.67%
FREE CASH FLOW
Cash From Operating Activities $8.830M $11.01M $10.26M
Capital Expenditures -$560.0K -$400.0K -$50.00K
Free Cash Flow $9.390M $11.41M $10.31M
YoY Change -8.92% 9.19% 4.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Shell Company
EntityShellCompany
false
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Registrant Name
EntityRegistrantName
MESA LABORATORIES INC /CO
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000724004
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4370468
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Security12b Title
Security12bTitle
Common Stock, no par value
dei Trading Symbol
TradingSymbol
mlab
mlab Deferred Tax Liability Related To Conversion Option Associated With Convertible Senior Notes
DeferredTaxLiabilityRelatedToConversionOptionAssociatedWithConvertibleSeniorNotes
CY2019Q4 mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
-78000
CY2018Q4 mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
-160000
mlab Amortization Of Inventory Stepup Cost
AmortizationOfInventoryStepupCost
5134000
mlab Amortization Of Inventory Stepup Cost
AmortizationOfInventoryStepupCost
mlab Business Combination Subsequent Adjustment To Initial Contingent Consideration Liability
BusinessCombinationSubsequentAdjustmentToInitialContingentConsiderationLiability
-52000
mlab Business Combination Subsequent Adjustment To Initial Contingent Consideration Liability
BusinessCombinationSubsequentAdjustmentToInitialContingentConsiderationLiability
-32000
mlab Contract With Customer Liability Increase During Period Net Of Revenue Recognized
ContractWithCustomerLiabilityIncreaseDuringPeriodNetOfRevenueRecognized
6834000
mlab Deferred Tax Liability Related To Conversion Option Associated With Convertible Senior Notes
DeferredTaxLiabilityRelatedToConversionOptionAssociatedWithConvertibleSeniorNotes
8448000
mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
-986000
mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
-1018000
CY2019Q4 mlab General And Administrative Research And Development Other Expense
GeneralAndAdministrativeResearchAndDevelopmentOtherExpense
-19880000
CY2018Q4 mlab General And Administrative Research And Development Other Expense
GeneralAndAdministrativeResearchAndDevelopmentOtherExpense
-14686000
mlab General And Administrative Research And Development Other Expense
GeneralAndAdministrativeResearchAndDevelopmentOtherExpense
-42471000
mlab General And Administrative Research And Development Other Expense
GeneralAndAdministrativeResearchAndDevelopmentOtherExpense
-38648000
mlab Increase Decrease In Inventory Reserve
IncreaseDecreaseInInventoryReserve
-578000
mlab Increase Decrease In Inventory Reserve
IncreaseDecreaseInInventoryReserve
-49000
CY2019Q4 mlab Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
CY2018Q4 mlab Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
180000
mlab Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
251000
mlab Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
182000
CY2019Q3 mlab Sale Of Stock Underwriter Options Shares
SaleOfStockUnderwriterOptionsShares
56250
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3780000
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2898000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
19503000
CY2019Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12516000
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3354000
CY2019Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2356000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8005000
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4004000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
857000
CY2019Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
334000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15170000
CY2019Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11080000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4236000
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1815000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
21646000
CY2019Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3260000
CY2018Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
695000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5310000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2424000
CY2019Q4 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
3182000
CY2018Q4 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
535000
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
4324000
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
1406000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
151000
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
121000
CY2019Q4 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1295000
CY2018Q4 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2002000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
CY2019Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2565000
CY2018Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2190000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5895000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5418000
CY2019Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
972000
CY2018Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
355000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
32000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
298000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
3669000
CY2019Q4 us-gaap Asset Impairment Charges
AssetImpairmentCharges
276000
CY2018Q4 us-gaap Asset Impairment Charges
AssetImpairmentCharges
3669000
CY2019Q4 us-gaap Assets
Assets
423467000
CY2019Q1 us-gaap Assets
Assets
156767000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
120703000
CY2019Q1 us-gaap Assets Current
AssetsCurrent
33623000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-11000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-677000
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
528000
CY2019Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
45000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
73979000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10185000
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5469000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5729000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
63794000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
260000
CY2019Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2019Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4370468
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3890138
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4370468
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3890138
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
155622000
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
39823000
CY2019Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2111000
CY2018Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
200000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9080000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4063000
CY2019Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2019Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4426000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6828000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6363000
CY2019Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3965000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4432000
CY2019Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
138967000
CY2019Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
40989000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
135091000
CY2019Q4 us-gaap Cost Of Revenue
CostOfRevenue
16978000
CY2018Q4 us-gaap Cost Of Revenue
CostOfRevenue
11048000
us-gaap Cost Of Revenue
CostOfRevenue
37187000
us-gaap Cost Of Revenue
CostOfRevenue
31387000
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
225000
CY2019Q1 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
1323000
CY2019Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
23702000
CY2019Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1077000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7501000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7162000
CY2019Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
624000
CY2019Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
697000
CY2019Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
698000
CY2018Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
610000
CY2018Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
616000
CY2018Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
617000
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.06
CY2018Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.58
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.06
CY2018Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.51
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-208000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-150000
CY2019Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.11
CY2018Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.095
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.207
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.086
CY2019Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6569000
CY2019Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7324000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
47014000
CY2019Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
74208000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
88077000
CY2019Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
33219000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
288000
CY2019Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11605000
CY2018Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7731000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26806000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22824000
CY2019Q4 us-gaap Goodwill
Goodwill
189597000
CY2019Q1 us-gaap Goodwill
Goodwill
66377000
CY2019Q4 us-gaap Gross Profit
GrossProfit
14677000
CY2018Q4 us-gaap Gross Profit
GrossProfit
15634000
us-gaap Gross Profit
GrossProfit
46292000
us-gaap Gross Profit
GrossProfit
45302000
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5203000
CY2018Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
948000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3821000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6654000
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-573000
CY2018Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
90000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
792000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
572000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
64000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
311000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-11000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-893000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4396000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3375000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
227000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-179000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-605000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1302000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2410000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
4611000
CY2019Q4 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
CY2018Q4 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
10000
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
25000
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
15000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
88077000
CY2019Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
33219000
CY2019Q4 us-gaap Interest Expense
InterestExpense
1929000
CY2018Q4 us-gaap Interest Expense
InterestExpense
395000
us-gaap Interest Expense
InterestExpense
3522000
us-gaap Interest Expense
InterestExpense
1359000
CY2019Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
1888000
CY2018Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
us-gaap Interest Expense Debt
InterestExpenseDebt
2911000
us-gaap Interest Expense Debt
InterestExpenseDebt
CY2019Q4 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
593000
CY2018Q4 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
909000
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
909000
CY2019Q1 us-gaap Interest Payable Current
InterestPayableCurrent
80000
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13915000
CY2019Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2524000
CY2019Q4 us-gaap Inventory Net
InventoryNet
18804000
CY2019Q1 us-gaap Inventory Net
InventoryNet
6772000
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
8144000
CY2019Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
6804000
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3561000
CY2019Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2984000
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
306000
CY2019Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
428000
CY2019Q4 us-gaap Lease Cost
LeaseCost
311000
us-gaap Lease Cost
LeaseCost
718000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2490000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
340000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
676000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1119000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
355000
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
134000
CY2019Q4 us-gaap Liabilities
Liabilities
189296000
CY2019Q1 us-gaap Liabilities
Liabilities
45456000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
423467000
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
156767000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
25245000
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
23661000
CY2019Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
CY2019Q1 us-gaap Litigation Reserve Current
LitigationReserveCurrent
3300000
CY2019Q4 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
CY2018Q4 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
3300000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
CY2019Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
2125000
CY2019Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
20613000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16057000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-185037000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3825000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
18156000
CY2019Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
57108
CY2019Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
230883000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20292000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3029000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6082000
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4597000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3062000
CY2019Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4630000
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4230000
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
994000
CY2018Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
858000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
5
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
18058000
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
14314000
us-gaap Operating Expenses
OperatingExpenses
39697000
us-gaap Operating Expenses
OperatingExpenses
38080000
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-3381000
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1320000
us-gaap Operating Income Loss
OperatingIncomeLoss
6595000
us-gaap Operating Income Loss
OperatingIncomeLoss
7222000
CY2019Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
301000
us-gaap Operating Lease Cost
OperatingLeaseCost
659000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2356000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1144000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
CY2019Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
313000
us-gaap Operating Lease Payments
OperatingLeasePayments
698000
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.039
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y73D
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1741000
CY2019Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1234000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2513000
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
186000
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-876000
CY2019Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6741000
CY2018Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1312000
CY2018Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-49000
CY2018Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-658000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6051000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2019000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1382000
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
105000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-255000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-135000
CY2019Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
107000
CY2018Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
748000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
791000
us-gaap Paid In Kind Interest
PaidInKindInterest
2002000
us-gaap Paid In Kind Interest
PaidInKindInterest
CY2019Q3 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
9427000
us-gaap Payments Of Dividends
PaymentsOfDividends
2019000
us-gaap Payments Of Dividends
PaymentsOfDividends
1843000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
184102000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
4840000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
935000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1207000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4630000
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1598000
CY2019Q4 us-gaap Prepaid Taxes
PrepaidTaxes
3787000
CY2019Q1 us-gaap Prepaid Taxes
PrepaidTaxes
2552000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
167070000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
CY2019Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
84995000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
84995000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
2000000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2222000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3848000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3588000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22352000
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22225000
us-gaap Repayments Of Debt
RepaymentsOfDebt
23000000
us-gaap Repayments Of Debt
RepaymentsOfDebt
19125000
CY2019Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2110000
CY2018Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
860000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4044000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2539000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
74313000
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
73303000
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31655000
CY2018Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26682000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
83479000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
76689000
CY2019Q4 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1443000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1516000
CY2019Q4 us-gaap Selling Expense
SellingExpense
4067000
CY2018Q4 us-gaap Selling Expense
SellingExpense
2054000
us-gaap Selling Expense
SellingExpense
8549000
us-gaap Selling Expense
SellingExpense
5748000
us-gaap Share Based Compensation
ShareBasedCompensation
5310000
us-gaap Share Based Compensation
ShareBasedCompensation
2424000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
28000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
99.69
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
29000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
354000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
313000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
94.04
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
105.03
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
85.35
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
205.87
CY2019Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
210
CY2019Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
431250
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
42000
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
84995000
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
868000
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1182000
CY2019Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3260000
CY2018Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
739000
CY2018Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
990000
CY2018Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
695000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2709000
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
798000
CY2019Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
341000
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3043000
CY2018Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
133000
CY2018Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
412000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
234171000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
111311000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
119047000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
229157000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
99361000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
105451000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
106903000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
107593000
CY2019Q4 us-gaap Variable Lease Cost
VariableLeaseCost
10000
us-gaap Variable Lease Cost
VariableLeaseCost
59000
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4367000
CY2018Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4045000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4418000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4037000
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4367000
CY2018Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3855000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4142000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3840000

Files In Submission

Name View Source Status
0001437749-20-002116-index-headers.html Edgar Link pending
0001437749-20-002116-index.html Edgar Link pending
0001437749-20-002116.txt Edgar Link pending
0001437749-20-002116-xbrl.zip Edgar Link pending
ex_167049.htm Edgar Link pending
ex_167050.htm Edgar Link pending
ex_167051.htm Edgar Link pending
ex_167052.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mlab-20191231.xml Edgar Link completed
mlab-20191231.xsd Edgar Link pending
mlab-20191231_cal.xml Edgar Link unprocessable
mlab-20191231_def.xml Edgar Link unprocessable
mlab-20191231_lab.xml Edgar Link unprocessable
mlab-20191231_pre.xml Edgar Link unprocessable
mlab20191231b_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending